--- title: "Replimune prices $150M underwritten offering of common stock and pre-funded warrants" type: "News" locale: "en" url: "https://longbridge.com/en/news/295402602.md" description: "Replimune priced an underwritten offering of common stock and pre-funded warrants to raise approximately $150 million in gross proceeds. The deal includes 9,701,490 shares and warrants for 2,736,340 shares at $12.06 per share. Net proceeds are estimated at $140.5 million after expenses. Delivery is expected around August 11, 2026, under Form S-3 shelf registration." datetime: "2026-08-10T11:53:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295402602.md) - [en](https://longbridge.com/en/news/295402602.md) - [zh-HK](https://longbridge.com/zh-HK/news/295402602.md) generator: "portal-rs" --- # Replimune prices $150M underwritten offering of common stock and pre-funded warrants **Replimune priced an underwritten offering expected to raise approximately $150.0 million in gross proceeds.** **Key Highlights:** - Underwriting agreement for 9,701,490 shares and pre-funded warrants for 2,736,340 shares priced at $12.06/share (warrants $12.0599). - Net proceeds estimated at approximately $140.5 million after underwriting discounts, commissions and offering expenses. - Pre-funded warrants exercisable anytime; exercise restricted to avoid >9.99% ownership without 61 days' notice. - Delivery of securities expected on or about August 11, 2026, subject to customary closing conditions. - Offering made under Form S-3 shelf registration (Registration No. 333-287536); prospectus supplement to be filed with the SEC. Original SEC Filing: Replimune Group, Inc. \[ REPL \] - 8-K - Aug. 10, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [REPL.US](https://longbridge.com/en/quote/REPL.US.md) ## Related News & Research - [16:20 ETRobbins LLP Urges REPL Investors Who Lost Money Investing in Replimune to Contact the Firm for Information About Leading the Class Action](https://longbridge.com/en/news/296649920.md) - [Quantinno Capital Management LP Increases Stock Position in Replimune Group, Inc. $REPL](https://longbridge.com/en/news/296198190.md) - [Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering | JUNS Stock News](https://longbridge.com/en/news/296638594.md) - [RenX Enterprises Announces $2.6 Million Sale Agreement for Norman Berry Property | RENX Stock News](https://longbridge.com/en/news/296622710.md) - [QNB Corp. Announces Launch of Common Stock Offering | QNBC Stock News](https://longbridge.com/en/news/296398686.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**